Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Multicenter Assessment of ALD403 in Chronic Migraine

ClinicalTrials.gov ID: NCT02275117

Public ClinicalTrials.gov record NCT02275117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Dose-Ranging Phase 2 Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALD403 Administered Intravenously in Patients With Chronic Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.

Study identification

NCT ID
NCT02275117
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alder Biopharmaceuticals, Inc.
Industry
Enrollment
665 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2014 (Type not available)
Primary completion
Mar 2016 (Actual)
Completion
Nov 2016 (Actual)
Last update posted
Apr 8, 2020

2014 – 2016

United States locations

U.S. sites
82
U.S. states
30
U.S. cities
78
Facility City State ZIP Site status
Research Site Huntsville Alabama 35801 —
Research Site Mobile Alabama 36608 —
Research Site Phoenix Arizona 85027 —
Research Site Scottsdale Arizona 85259 —
Research Site Hot Springs Arkansas 71901 —
Research Site Little Rock Arkansas 72211 —
Research Site Anaheim California 92801 —
Research Site Encino California 91436 —
Reserach Site Long Beach California 90806 —
Research Site Los Angeles California 90036 —
Research Site Oakland California 94612 —
Research Site San Diego California 92108 —
Research Site San Francisco California 94102 —
Research Site Santa Monica California 90404 —
Research Site Stanford California 94305 —
Research Site Ventura California 93003 —
Research Site Colorado Springs Colorado 80918 —
Research Site Denver Colorado 80210 —
Research Site Stamford Connecticut 06905 —
Research Site Waterbury Connecticut 06708 —
Research Site Gainesville Florida 32607 —
Research Site Hallandale Florida 33009 —
Research Site Jacksonville Florida 32256 —
Research Site Miami Florida 33144 —
Research Site Miami Florida 33173 —
Research Site North Miami Florida 33161 —
Research Site Orlando Florida 32801 —
Research Site Orlando Florida 32806 —
Research Site Tampa Florida 33606 —
Research Site Atlanta Georgia 30022 —
Research Site Atlanta Georgia 30342 —
Research Site Chicago Illinois 60607 —
Research Site Chicago Illinois 60640 —
Research Site Evansville Illinois 47714 —
Research Site Normal Illinois 61761 —
Research Site Prairie Village Kansas 66206 —
Research Site Wichita Kansas 67207 —
Research Site Louisville Kentucky 40207 —
Research Site New Orleans Louisiana 70115 —
Research Site Shreveport Louisiana 71105 —
Research Site Boston Massachusetts 21310 —
Research Site Brockton Massachusetts 02301 —
Research Site New Bedford Massachusetts 02740 —
Research Site Watertown Massachusetts 02472 —
Research Site Ann Arbor Michigan 48104 —
Research Site Springfield Missouri 65807 —
Research Site St Louis Missouri 63141 —
Research Site Omaha Nebraska 68134 —
Research Site Princeton New Jersey 08540 —
Research Site Albuquerque New Mexico 87102 —
Research Site Albany New York 12208 —
Research Site Amherst New York 14226 —
Research Site Brooklyn New York 11235 —
Research Site Endwell New York 13760 —
Research Site New York New York 10019 —
Research Site Rochester New York 14609 —
Research Site The Bronx New York 10461 —
Research Site Cary North Carolina 27518 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Canton Ohio 44718 —
Research Site Cincinnati Ohio 45255 —
Research Site Cleveland Ohio 44195 —
Research Site Columbus Ohio 43213 —
Research Site Dayton Ohio 45424 —
Research Site Oklahoma City Oklahoma 73116 —
Research Site Portland Oregon 97239 —
Research Site Philadelphia Pennsylvania 19107 —
Research Site Willow Grove Pennsylvania 19090 —
Research Site Mt. Pleasant South Carolina 29464 —
Research Site Chattanooga Tennessee 37421 —
Research Site Memphis Tennessee 38119 —
Research Site Austin Texas 78705 —
Research Site Dallas Texas 75231 —
Research Site Fort Worth Texas 76104 —
Research Site Houston Texas 77058 —
Research Site Orem Utah 84058 —
Research Site Salt Lake City Utah 84109 —
Research Site Richmond Virginia 23226 —
Research Site Virginia Beach Virginia 23454 —
Research Site Bellevue Washington 98007 —
Research Site Seattle Washington 98105 —
Research Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02275117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2020 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02275117 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →